Heather Knight - 01 Mar 2023 Form 3/A Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
EVP, Group Pres, Med Products
Signature
/s/ Matthew Rice, as attorney in-fact for Heather Knight
Issuer symbol
BAX
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
3/A
Filing time
14 Feb 2024, 16:58:41 UTC
Date Of Original Report
03 Mar 2023
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BAX Common Stock, $1 par value 34,132 01 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on March 3, 2023, which inadvertently reported 33,011 shares of Baxter common stock beneficially owned by the reporting person instead of the 34,132 shares reported herein.